tiprankstipranks
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
ANTX
AN2 Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Financial Statements

106 Followers

AN2 Therapeutics, Inc. Financial Overview

AN2 Therapeutics, Inc.'s market cap is currently $167.38M. The company's EPS TTM is $-1.16; its P/E ratio is -0.99; AN2 Therapeutics, Inc. is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -77.00K$ 0.00
Operating Income$ -38.11M$ -54.55M$ -69.64M$ -42.26M$ -21.57M
EBITDA$ -38.11M$ 3.23M$ 4.90M$ -40.88M$ -21.57M
Net Income$ -35.17M$ -51.32M$ -64.73M$ -40.96M$ -21.54M
Balance Sheet
Cash & Short-Term Investments$ 58.00M$ 83.62M$ 107.30M$ 96.06M$ 58.55M
Total Assets$ 61.95M$ 92.09M$ 138.74M$ 102.56M$ 65.32M
Total Debt$ 0.00$ 0.00$ 0.00$ 53.00K$ 0.00
Net Debt$ -19.94M$ -21.35M$ -15.65M$ -27.17M$ -12.10M
Total Liabilities$ 8.89M$ 10.24M$ 14.04M$ 7.19M$ 3.41M
Stockholders' Equity$ 53.06M$ 81.85M$ 124.70M$ 95.37M$ 61.91M
Cash Flow
Free Cash Flow$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
Operating Cash Flow$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
Investing Cash Flow$ 28.31M$ 54.59M$ -43.28M$ -21.77M$ -50.02M
Financing Cash Flow$ 113.00K$ 372.00K$ 84.99M$ 70.36M$ 78.53M
Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History

Income Statement >

AN2 Therapeutics, Inc. Debt to Assets

Balance Sheet >

AN2 Therapeutics, Inc. Cash Flow

Cash Flow >

AN2 Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >